MEPs seek Commission answers over EU trade officials’ contacts with PMI

Jan.15
MEPs seek Commission answers over EU trade officials’ contacts with PMI
POLITICO reports that five members of the European Parliament’s health committee want to invite the European Commission to answer questions about its contacts with Philip Morris International (PMI), following a POLITICO and The Examination investigation into extensive meetings between EU trade officials and tobacco lobbyists.

Key points

 

• Five health committee MEPs want the Commission invited to answer questions about contacts with PMI

• POLITICO and The Examination reported extensive meetings between EU trade officials and tobacco lobbyists

• Documents indicate discussions on overseas market barriers and at least three subsequent actions that would have benefited PMI

• WHO treaty obligations cited: interaction limited to “strictly necessary” and meetings must be transparent; not all were disclosed via normal channels

• A Tobacco Products Directive overhaul targeting vapes is due this year, a process expected to draw intensive lobbying

 


 

2Firsts, January 15, 2026 – According to POLITICO, the European Commission is facing rising pressure from lawmakers to explain its contacts with Philip Morris International (PMI) after a POLITICO and The Examination investigation reported extensive meetings between EU trade officials and tobacco lobbyists.

 

POLITICO reports that five members of the European Parliament’s health committee confirmed they want to invite the Commission to answer questions amid concerns it may have violated global rules on tobacco lobbying.

 

The report says documents show PMI discussed overseas market barriers for its tobacco and nicotine products with EU trade officials, who later took action at least three times that would have benefited the company. In one email, PMI thanked EU trade officials for the “great help” they had provided.

 

POLITICO notes the EU has signed a World Health Organization treaty stating governments should limit their interaction with the tobacco industry to what is “strictly necessary” in order to regulate the sector, and that any meetings must be transparent. The report adds that not all meetings were disclosed through the Commission’s normal channels.

 

The report says the issue comes as the Commission seeks to reassert itself as a global leader in tobacco control, with an overhaul of its Tobacco Products Directive to tackle vapes due to arrive this year — a process expected to attract intensive lobbying.

 

MEP Romana Jerković (S&D) is quoted saying commercial interests are winning over public health objectives and calling for a clear line between public policy and tobacco lobbying. The report also attributes the initial call for a Commission appearance to Nicolás González Casares (S&D), supported by Tiemo Wölken (S&D), Tilly Metz (Greens) and Stine Bosse (Renew).

 

POLITICO reports the decision to invite the Commission will rest with health committee party coordinators and chair Adam Jarubas (EPP), who did not immediately respond to a request for comment.

 

A Commission spokesperson told POLITICO and The Examination last month that the EU executive “strictly follows” the WHO Framework Convention on Tobacco Control and “does not shape, influence or lobby for specific health policies in third countries on behalf of any industry.” The report adds that a Commission spokesperson did not immediately respond on whether trade officials would appear in Parliament if invited.

 

Image source: POLITICO

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Reuters: More “Made in America” Vape Products Appear in the U.S. Amid Trump Tariffs and Crackdown
Reuters: More “Made in America” Vape Products Appear in the U.S. Amid Trump Tariffs and Crackdown
According to Reuters, the U.S. vaping market has recently seen an increase in products marketed as “Made in America” amid the Trump administration’s stronger enforcement against unauthorized vape brands and increased trade tariff pressure on Chinese goods. Since October 2025, at least eight new vape brands highlighting American credentials have entered the U.S. market, and none of them has authorization for sale. Brands mentioned by Reuters include Maxus Star and OneTank.
Apr.08
BAT Rothmans Upgrades neo™ Boost for glo™ HYPER Series
BAT Rothmans Upgrades neo™ Boost for glo™ HYPER Series
BAT Rothmans said on April 13 that its heated tobacco brand glo™ will launch an upgraded version of neo™ Boost, the dedicated stick for the HYPER series. The company said the refresh focuses on strengthening freshness and cooling sensations to improve the overall user experience.
Apr.14 by 2FIRSTS.ai
Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Group reported its first-quarter 2026 results on April 30. Net revenues were $5.43 billion, up 3.2% year on year, while revenues net of excise taxes were $4.76 billion, up 5.3%. Reported diluted EPS was $1.30, up more than 100%, and adjusted diluted EPS was $1.32, up 7.3%.
May.06 by 2FIRSTS.ai
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Center for Tobacco Products Acting Director Bret Koplow issued a statement on May 7 outlining new steps to accelerate tobacco product premarket application review. The statement said CTP reduced the backlog of applications by approximately 70% in 2025 and that there is no longer a queue for PMTAs pending acceptance review.
May.09 by 2FIRSTS.ai
Australian Government and Spotify Launch Third Phase of Youth Vaping Education Campaign
Australian Government and Spotify Launch Third Phase of Youth Vaping Education Campaign
The Australian Government and Spotify have launched the third phase of the Youth Vaping Education Campaign under the theme “Buddy Up – Make a Pact to Quit Together.” This phase shifts the focus toward peer and community support by encouraging young people to quit vaping together.
Apr.16 by 2FIRSTS.ai
Trump Reportedly Signs Off on Plan to Fire FDA Commissioner Marty Makary
Trump Reportedly Signs Off on Plan to Fire FDA Commissioner Marty Makary
According to The Wall Street Journal, people familiar with the matter said President Trump has signed off on a plan to fire FDA Commissioner Marty Makary, though the plan is not yet final and could change. The report said Makary’s tenure has included clashes over vaping, abortion and drug policy, and that some senior administration officials view him as struggling to manage the agency.
May.09 by 2FIRSTS.ai